Sierra Summit Advisors »

Ambrx Biopharma shares owned by Sierra Summit Advisors

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Sierra Summit Advisors from 13F filings

Historical chart of Sierra Summit Advisors investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by Sierra Summit Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by Sierra Summit Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $530k 37k 14.24

More positions owned by Sierra Summit Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Intuitive Surgical Com New (ISRG)
Lululemon Athletica (LULU)
Boston Scientific Corporation (BSX)
Meta Platforms Cl A (META)
Palo Alto Networks (PANW)
Celsius Hldgs Com New (CELH)
salesforce (CRM)
MercadoLibre (MELI)
Costco Wholesale Corporation (COST)
Visa Com Cl A (V)

View all positions for Sierra Summit Advisors

Top funds holding Ambrx Biopharma

Darwin Global Management
Cormorant Asset Management
Paradigm Biocapital Advisors
D. E. Shaw & Co
Nextech Invest
Balyasny Asset Management
Citadel Advisors
Logos Global Management
VR Adviser
Vanguard Group
T. Rowe Price Associates
Millennium Management
Goldman Sachs Group
Federated Investors
OrbiMed Advisors

View all funds holding Ambrx Biopharma